{"transactions":[{"id":955411,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70619,"kind":"person","name":"McIver Zachariah","position":1,"cik":"0002050056","reported_name":"McIver Zachariah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-02T21:00:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":101500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":101500,"derivative":{"exercise_price":13.65,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":101500},"source":{"system":"sec-edgar","filing":"0002050056-26-000002","document":"form4-01022026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2050056/000205005626000002/form4-01022026_090105.xml","form_type":"4"}},{"id":955410,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70619,"kind":"person","name":"McIver Zachariah","position":1,"cik":"0002050056","reported_name":"McIver Zachariah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-02T21:00:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027."}],"balance_after":52286,"source":{"system":"sec-edgar","filing":"0002050056-26-000002","document":"form4-01022026_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2050056/000205005626000002/form4-01022026_090105.xml","form_type":"4"}},{"id":955409,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70619,"kind":"person","name":"McIver Zachariah","position":1,"cik":"0002050056","reported_name":"McIver Zachariah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-02T21:00:10.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":2714,"price":13.73,"value":37263.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":23286,"source":{"system":"sec-edgar","filing":"0002050056-26-000002","document":"form4-01022026_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050056/000205005626000002/form4-01022026_090105.xml","form_type":"4"}},{"id":1315697,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70619,"kind":"person","name":"McIver Zachariah","position":1,"cik":"0002050056","reported_name":"McIver Zachariah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T20:10:13.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":91000,"derivative":{"exercise_price":53.24,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001415889-25-000677","document":"form4-01032025_080111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2050056/000141588925000677/form4-01032025_080111.xml","form_type":"4"}},{"id":1315696,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70619,"kind":"person","name":"McIver Zachariah","position":1,"cik":"0002050056","reported_name":"McIver Zachariah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-03T20:10:13.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026."}],"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001415889-25-000677","document":"form4-01032025_080111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2050056/000141588925000677/form4-01032025_080111.xml","form_type":"4"}}]}